Colossal Biosciences
About Colossal Biosciences
Colossal Biosciences is a genetics and biosciences company that aims to solve the problem of extinction through de-extinction, a functional application of advanced gene editing technology. The company is working to rebuild the DNA of lost megafauna and other creatures that had a measurably positive impact on fragile ecosystems. Colossal is led by CEO Ben Lamm and anchored by some of the most recognized names in science and industry.
Recent News
Hottest Deals In Tech Push Crunchbase Unicorn Board Toward $7T In Value
Uber Eats Scoops US Grand Effie
Hiltzik: Are Dodos and Mammoths Coming Back From Extinction? Don't Count on It
Chickens without Eggs? De-Extinction Company Creates Artificial Egg.
Colossal Bio Grows Chicks in 3D-Printed Artificial Eggs. Breakthrough or Copycat Technology?
Colossal Biosciences Hatches Live Chicks From Fully Artificial Egg, Paving Way for Moa De‑Extinction
Adam Draper Backs AI Cinema Startup M00m World with Undisclosed Investment
How One Startup Turned Extinction Into a Multi-Billion-Dollar Science Movement
How a ‘TikTok Doctorate’ Made 26-Year-Old Griffin Johnson a Venture Capitalist
Designer Baby Companies Are in Turmoil
Colossal Biosciences' Dire Wolves Reach Breeding Age, Paving Way for De‑Extinction Market
2026 Predictions: Historic FDA Shift, Plausible Mechanisms, Bespoke Tx, RFK Jr., Biotechs, State AGs, Peptides, Embryos
Colossal Biosciences Wins 2025 The Screamers Award for Science Hype on Dire Wolf De-Extinction Claim
These Companies Were Called Moonshots. Now They’re Worth Billions